Nanomedicine – Immunotherapeutics Solicitation
The Ming Hsieh Institute aims to make USC an international leader in translational cancer research that bridges basic science, engineered devices, synthesized molecules and materials, and medicine. Established in 2010 through a generous gift from Ming Hsieh (a USC graduate of the Viterbi School of Engineering and founder of Cogent Systems), the centerpiece of the Ming Hsieh Institute is integrated engineering, scientific and medical research that speeds discovery and creates the pathways by which research rapidly improves the lives of patients living with cancer. By embarking on this new interdisciplinary direction, we aim to develop new targeted therapeutic approaches to cancer.
The Ming Hsieh Institute seeks proposals that will initiate multi-disciplinary research teams employing computational biology, protein chemistry, physics, chemistry, pharmacology, and/or engineering, for the purpose of developing new treatments or diagnostics for patients with cancer. Proposals should demonstrate that a modest seed investment will have significant impact, either through initiating a novel research concept, or accelerating research into clinical trials.
Proposal Deadline: 5 pm, Tuesday, January 22, 2019; Updated: 12/03/18
Submit your proposal application utilizing the new Office of Research application submission and reporting portal.
Go to USC Application Portal to log in (or create an account for yourself), using your USC email address.
Important: You may experience problems with the online application if using the browser Internet Explorer. If you experience problems, it is advisable to access the application system through a different browser, such as Mozilla Firefox or Google Chrome.
For questions regarding the proposal submission process, please contact the Office of Research at (email@example.com or 213-821-8163).